These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

579 related articles for article (PubMed ID: 23379543)

  • 1. Recurrence rates of aggressive histologic types of basal cell carcinoma after treatment with electrodesiccation and curettage alone.
    Blixt E; Nelsen D; Stratman E
    Dermatol Surg; 2013 May; 39(5):719-25. PubMed ID: 23379543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recurrence rates of primary basal cell carcinoma in facial risk areas treated with curettage and electrodesiccation.
    Rodriguez-Vigil T; Vázquez-López F; Perez-Oliva N
    J Am Acad Dermatol; 2007 Jan; 56(1):91-5. PubMed ID: 17190625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mohs' micrographic surgery for treatment of basal cell carcinoma of the face--results of a retrospective study and review of the literature.
    Smeets NW; Kuijpers DI; Nelemans P; Ostertag JU; Verhaegh ME; Krekels GA; Neumann HA
    Br J Dermatol; 2004 Jul; 151(1):141-7. PubMed ID: 15270883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High recurrence rates of Basal cell carcinoma after mohs surgery in patients with chronic lymphocytic leukemia.
    Mehrany K; Weenig RH; Pittelkow MR; Roenigk RK; Otley CC
    Arch Dermatol; 2004 Aug; 140(8):985-8. PubMed ID: 15313816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recurrence rates of periocular basal cell carcinoma following Mohs micrographic surgery: a retrospective study.
    Sin CW; Barua A; Cook A
    Int J Dermatol; 2016 Sep; 55(9):1044-7. PubMed ID: 27152747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 5-year recurrence rates of Mohs micrographic surgery for aggressive and recurrent facial basal cell carcinoma.
    Paoli J; Daryoni S; Wennberg AM; Mölne L; Gillstedt M; Miocic M; Stenquist B
    Acta Derm Venereol; 2011 Oct; 91(6):689-93. PubMed ID: 21681360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surgical excision versus Mohs' micrographic surgery for basal cell carcinoma of the face: A randomised clinical trial with 10 year follow-up.
    van Loo E; Mosterd K; Krekels GA; Roozeboom MH; Ostertag JU; Dirksen CD; Steijlen PM; Neumann HA; Nelemans PJ; Kelleners-Smeets NW
    Eur J Cancer; 2014 Nov; 50(17):3011-20. PubMed ID: 25262378
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Basal cell carcinoma of the head region: therapeutical results of 350 lesions treated with Mohs micrographic surgery.
    Veronese F; Farinelli P; Zavattaro E; Zuccoli R; Bonvini D; Leigheb G; Colombo E
    J Eur Acad Dermatol Venereol; 2012 Jul; 26(7):838-43. PubMed ID: 21707774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low recurrence rate of head and neck basal cell carcinoma treated with Mohs micrographic surgery: A retrospective study of 1021 cases.
    Kuiper EM; van den Berge BA; Spoo JR; Kuiper J; Terra JB
    Clin Otolaryngol; 2018 Oct; 43(5):1321-1327. PubMed ID: 29953746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Duplicitous growth of infiltrative basal cell carcinoma: Analysis of clinically undetected tumor extent in a paired case-control study.
    Hendrix JD; Parlette HL
    Dermatol Surg; 1996 Jun; 22(6):535-9. PubMed ID: 8646468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Histologic risk factors of basal cell carcinoma of the face, about 184 cases].
    Wavreille O; Martin De Lassalle E; Wavreille G; Mortier L; Martinot Duquennoy V
    Ann Chir Plast Esthet; 2012 Dec; 57(6):542-8. PubMed ID: 22534511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Basal cell carcinoma treated with Mohs micrographic surgery in young Ibero-American patients.
    Aluma-Tenorio MS; Ávila-Álvarez A; Jaimes N; Caballero-Uribe N; González A; Terzian LR; Ocampo-Candiani J; Zuluaga MA; Garza-Rodríguez V; Tamayo-Betancur MC; Cuesta-Castro DP; Garcés JR; Ruiz-Salas V; Goldberg L; Kimyai-Asadi A
    Int J Dermatol; 2018 Dec; 57(12):1447-1453. PubMed ID: 30168850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Basosquamous carcinoma and metatypical basal cell carcinoma: a review of treatment with Mohs micrographic surgery.
    Allen KJ; Cappel MA; Killian JM; Brewer JD
    Int J Dermatol; 2014 Nov; 53(11):1395-403. PubMed ID: 24961583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perianal and genital basal cell carcinoma: A clinicopathologic review of 51 cases.
    Gibson GE; Ahmed I
    J Am Acad Dermatol; 2001 Jul; 45(1):68-71. PubMed ID: 11423837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incompletely excised basal cell carcinoma: residual tumor rates at Mohs re-excision.
    Palmer VM; Wilson PR
    Dermatol Surg; 2013 May; 39(5):706-18. PubMed ID: 23294110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Basal cell carcinoma with mixed histology: a possible pathogenesis for recurrent skin cancer.
    Cohen PR; Schulze KE; Nelson BR
    Dermatol Surg; 2006 Apr; 32(4):542-51. PubMed ID: 16681663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cryosurgery and curettage-cryosurgery for basal cell carcinomas of the mid-face.
    Samain A; Boullié MC; Duval-Modeste AB; Joly P
    J Eur Acad Dermatol Venereol; 2015 Jul; 29(7):1291-6. PubMed ID: 25354233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Superficial radiotherapy for patients with basal cell carcinoma: recurrence rates, histologic subtypes, and expression of p53 and Bcl-2.
    Zagrodnik B; Kempf W; Seifert B; Müller B; Burg G; Urosevic M; Dummer R
    Cancer; 2003 Dec; 98(12):2708-14. PubMed ID: 14669293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Basal cell carcinoma treated with Mohs surgery in Australia III. Perineural invasion.
    Leibovitch I; Huilgol SC; Selva D; Richards S; Paver R
    J Am Acad Dermatol; 2005 Sep; 53(3):458-63. PubMed ID: 16112353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surgical excision versus Mohs' micrographic surgery for primary and recurrent basal-cell carcinoma of the face: a prospective randomised controlled trial with 5-years' follow-up.
    Mosterd K; Krekels GA; Nieman FH; Ostertag JU; Essers BA; Dirksen CD; Steijlen PM; Vermeulen A; Neumann H; Kelleners-Smeets NW
    Lancet Oncol; 2008 Dec; 9(12):1149-56. PubMed ID: 19010733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.